Skip to main content
All lobbying filings

BROWNSTEIN HYATT FARBER SCHRECK, LLP

BROWNSTEIN HYATT FARBER SCHRECK, LLP filed a Q3 report for NOVAVAX, INC. on October 16, 2025, reporting $30,000 in lobbying income.

Lobbying for NOVAVAX, INC. · Biotechnology company

All filings by BROWNSTEIN HYATT FARBER SCHRECK, LLP · Everything NOVAVAX, INC. has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 16, 2025
Income
$30,000
What the client paid this registrant for the period.
Client based in
Maryland

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Issues related to federal vaccine programs and vaccine regulatory frameworks. FDA funding and advocacy

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem